Diabetic Foot Ulcer Clinical Trial in Coconut Creek, FL

If you or a loved one is suffering from diabetic foot ulcers, please complete the form below and see if you are eligible for the ActiGraft® Clinical Trial About ActiGraft® – FDA-cleared, wound solution that uses a patient’s own blood to support the healing of chronic wounds.

ActiGraft® based on RedDress’ proprietary patented technology, is an FDA-cleared wound care solution that enables health care providers to produce – in real time – an in vitro blood clot from a patient’s whole blood. Once applied, the blood clot serves as a protective covering and supports wound healing processes which naturally occur in the patient’s body. ActiGraft® is named one of the top 10 innovations in podiatry. ActiGraft’s technology is innovating the way we treat chronic wounds by managing each stage of the wound healing process.

How does ActiGraft work?

^{Actigraft Treatment Progression}

When injured, your skin is capable of repairing itself and healing the wound. This happens through 4 overlapping processes—hemostasis, inflammation, proliferation and remodeling. For these processes to work, it’s essential that blood can get to the site of the wound. However, factors like illness, poor circulation, continued pressure, etc. can prevent blood flow to the wound and hinder the healing process. When this happens, an ulcer may form.

ActiGraft enables health care providers to produce—in real time—in vitro blood clots from the patient’s blood. Applying this blood clot to the site of the wound recreates the natural wound healing environment, and supports the body’s own healing processes.

Interested in the Clinical Trial? See if you are a candidate.